Team:USTC CHINA/Project/Results/FurtherWork
From 2013.igem.org
(Difference between revisions)
Line 72: | Line 72: | ||
<div><p>Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.</p></div> | <div><p>Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.</p></div> | ||
<img src="https://static.igem.org/mediawiki/igem.org/f/fd/20-%E6%9E%AF%E8%8D%89%E8%9B%8B%E7%99%BD%E8%A1%A8%E8%BE%BE.jpg" width="580" height="300"> | <img src="https://static.igem.org/mediawiki/igem.org/f/fd/20-%E6%9E%AF%E8%8D%89%E8%9B%8B%E7%99%BD%E8%A1%A8%E8%BE%BE.jpg" width="580" height="300"> | ||
- | <div class="atfigure" align="center" style="width:580px">Fig4. SDS PAGE shows the expression of LTB in WB800N</div> | + | <div class="atfigure" align="center" style="width:580px;font-size:14px;">Fig4. SDS PAGE shows the expression of LTB in WB800N</div> |
</div> | </div> | ||
</div> | </div> |
Revision as of 12:17, 27 September 2013